참고문헌
- Airley RE, Mobasheri A (2007). Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy, 53, 233-56. https://doi.org/10.1159/000104457
- Amann T, Hellerbrand C (2009). GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets, 13, 1411-27. https://doi.org/10.1517/14728220903307509
- Bagga S, Bracht J, Hunter S, et al (2005). Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell, 122, 553-63. https://doi.org/10.1016/j.cell.2005.07.031
- Bhowmick NA, Neilson EG, Moses HL (2004). Stromal fibroblasts in cancer initiation and progression. Nature, 432, 332-7. https://doi.org/10.1038/nature03096
- Boire A, Covic L, Agarwal A, et al (2005). PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell, 120, 303-13. https://doi.org/10.1016/j.cell.2004.12.018
- Brennecke J, Stark A, Russell RB, Cohen SM (2005). Principles of microRNA-target recognition. PLoS Biol, 3, 85. https://doi.org/10.1371/journal.pbio.0030085
- Cai J, Wu J, Zhang H, et al (2013). miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res, 73, 756-66. https://doi.org/10.1158/0008-5472.CAN-12-2651
- Calin GA, Croce CM (2006a). MicroRNA-cancer connection: the beginning of a new tale. Cancer Res, 66, 7390-4. https://doi.org/10.1158/0008-5472.CAN-06-0800
- Calin GA, Croce CM (2006b). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66. https://doi.org/10.1038/nrc1997
- Dimanche-Boitrel MT, Vakaet L Jr, Pujuguet P, et al (1994). In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int J Cancer, 56, 512-21. https://doi.org/10.1002/ijc.2910560410
- Farh KK, Grimson A, Jan C, et al (2005). The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science, 310, 1817-21. https://doi.org/10.1126/science.1121158
- Grum-Schwensen B, Klingelhofer J, Berg CH, et al (2005). Suppression of tumor development and metastasis formation in mice lacking the S100A4 (mts1) gene. Cancer Res, 65, 3772-80. https://doi.org/10.1158/0008-5472.CAN-04-4510
- Huang F, Lin C, Shi YH, Kuerban G (2013). MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells. Asian Pac J Cancer Prev, 14, 5915-20. https://doi.org/10.7314/APJCP.2013.14.10.5915
- Kim SY, Lee YH, Bae YS (2012). MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting alpha subunit of protein kinase CKII in human colorectal cancer cells. Biochem Biophys Res Commun, 429, 173-9. https://doi.org/10.1016/j.bbrc.2012.10.117
- Kuperwasser C, Chavarria T, Wu M, et al (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA, 101, 4966-71. https://doi.org/10.1073/pnas.0401064101
- Lai EC (2004). Predicting and validating microRNA targets. Genome Biol, 5, 115. https://doi.org/10.1186/gb-2004-5-9-115
- Lewis BP, Burge CB, Bartel DP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20. https://doi.org/10.1016/j.cell.2004.12.035
- Li H, Yin C, Zhang B, et al (2013a). PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186. Carcinogenesis, 34, 2145-55. https://doi.org/10.1093/carcin/bgt158
- Li Q, Zhang D, Wang Y, et al (2013b). MiR-21/Smad 7 signaling determines TGF-beta1-induced CAF formation. Scientific Reports, 3, 2038.
- Lim LP, Lau NC, Garrett-Engele P, et al (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-73. https://doi.org/10.1038/nature03315
- Lochter A, Galosy S, Muschler J, et al (1997). Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-tomesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol, 139, 1861-72. https://doi.org/10.1083/jcb.139.7.1861
- Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8. https://doi.org/10.1038/nature03702
- Mathupala SP, Ko YH, Pedersen PL (2009). Hexokinase-2 bound to mitochondria: cancer's stygian link to the “Warburg Effect” and a pivotal target for effective therapy. Semin Cancer Biol, 19, 17-24. https://doi.org/10.1016/j.semcancer.2008.11.006
- Olaso E, Santisteban A, Bidaurrazaga J, et al (1997). Tumordependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology, 26, 634-42.
- Olsen PH, Ambros V (1999). The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol, 216, 671-80. https://doi.org/10.1006/dbio.1999.9523
- Olumi AF, Grossfeld GD, Hayward SW, et al (1999). Carcinomaassociated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res, 59, 5002-11.
- Orimo A, Gupta PB, Sgroi DC, et al (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 121, 335-48. https://doi.org/10.1016/j.cell.2005.02.034
- Sternlicht MD, Lochter A, Sympson CJ, et al (1999). The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell, 98, 137-46. https://doi.org/10.1016/S0092-8674(00)81009-0
- Stetler-Stevenson WG, Aznavoorian S, Liotta LA (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol, 9, 541-73. https://doi.org/10.1146/annurev.cb.09.110193.002545
- Wan SM, Lv F, Guan T (2012). Identification of genes and microRNAs involved in ovarian carcinogenesis. Asian Pac J Cancer Prev, 13, 3997-4000. https://doi.org/10.7314/APJCP.2012.13.8.3997
- Wang Y, Stricker HM, Gou D, Liu L (2007). MicroRNA: past and present. Front Biosci, 12, 2316-29. https://doi.org/10.2741/2234
- Warburg O (1956). [Origin of cancer cells]. Oncologia, 9, 75-83. https://doi.org/10.1159/000223920
- Xie X, Lu J, Kulbokas EJ, et al (2005). Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature, 434, 338-45. https://doi.org/10.1038/nature03441
- Yang JH, Li JH, Shao P, et al (2011). starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic acids research, 39, 202-9. https://doi.org/10.1093/nar/gkq760
피인용 문헌
- MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1 vol.8, pp.1, 2015, https://doi.org/10.1186/s13048-015-0207-6
- miR-186 in Alzheimer's disease: a big hope for a small RNA? vol.137, pp.3, 2016, https://doi.org/10.1111/jnc.13573
- MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1 vol.37, pp.5, 2016, https://doi.org/10.1007/s13277-015-4558-9
- CAF cellular glycolysis: linking cancer cells with the microenvironment vol.37, pp.7, 2016, https://doi.org/10.1007/s13277-016-5049-3
- MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis vol.8, pp.5, 2017, https://doi.org/10.1038/cddis.2017.60
- Genetic alterations and epigenetic alterations of cancer-associated fibroblasts vol.13, pp.1, 2017, https://doi.org/10.3892/ol.2016.5451
- MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of pancreatic cancer vol.14, pp.3, 2017, https://doi.org/10.3892/etm.2017.4770
- MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C vol.14, pp.4, 2017, https://doi.org/10.3892/etm.2017.4908
- Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts vol.2018, pp.2314-6141, 2018, https://doi.org/10.1155/2018/6075403